Molecular Mechanisms in Gastric Carcinogenesis

作者: Jonathan Cools-Lartigue , Laura Baker , Lorenzo E. Ferri

DOI: 10.1007/978-3-319-15826-6_3

关键词:

摘要: Gastric cancer is the fourth most common malignancy worldwide and second leading cause of cancer-related death. Despite advances in medical surgical management this neoplasm, mortality remains high at approximately 60–80 % 5 years. A number factors have been proposed to account for these disappointing results. These include a lack understanding molecular events driving carcinogenesis blanket application cytotoxic therapies into patients with advanced disease without considering genetic abnormalities underlying their disease. Recently, numerous studies emerged elucidating aberrations tumor suppressors oncogenes epigenetic levels. led discovery key driver mutations thought underlie malignant process gastric cancer. Such permitted classification types along as opposed histologic lines. Accordingly, genes attractive targets individualized therapies. In chapter, mechanisms are reviewed

参考文章(133)
Ilaria Proserpio, Stefano Rausei, Sabrina Barzaghi, Francesco Frattini, Federica Galli, Domenico Iovino, Francesca Rovera, Luigi Boni, Gianlorenzo Dionigi, Graziella Pinotti, Multimodal treatment of gastric cancer World Journal of Gastrointestinal Surgery. ,vol. 6, pp. 55- 58 ,(2014) , 10.4240/WJGS.V6.I4.55
Jaclyn Yoong, Michael Michael, Trevor Leong, Targeted therapies for gastric cancer: current status. Drugs. ,vol. 71, pp. 1367- 1384 ,(2011) , 10.2165/11592530-000000000-00000
Yung Jue Bang, Jay Chang, Won Seog Kim, David Kim, David Kim, Keunchil Park, Seong Jin Kim, Expression of Transforming Growth Factor β Type II Receptor Reduces Tumorigenicity in Human Gastric Cancer Cells Cancer Research. ,vol. 57, pp. 2856- 2859 ,(1997)
Ituo Miyazaki, Shigekazu Ohoyama, Itasu Ninomiya, Akio Yamaguchi, Motohiro Tanaka, Yutaka Yonemura, Takuma Sasaki, Yoshio Endou, Sachio Fushida, Hironobu Kimura, Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Research. ,vol. 51, pp. 1034- 1038 ,(1991)
Suzuki T, Ishikawa T, Kobayashi M, Mai M, Ooi A, Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. American Journal of Pathology. ,vol. 151, pp. 761- 768 ,(1997)
Heike Allgayer, Rudolf Babic, Klaus Uwe Gruetzner, Anwar Tarabichi, Friedrich Wilhelm Schildberg, Markus Maria Heiss, c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems Journal of Clinical Oncology. ,vol. 18, pp. 2201- 2209 ,(2000) , 10.1200/JCO.2000.18.11.2201
Ivana Vucenik, Joseph P. Stains, Obesity and cancer risk: evidence, mechanisms, and recommendations. Annals of the New York Academy of Sciences. ,vol. 1271, pp. 37- 43 ,(2012) , 10.1111/J.1749-6632.2012.06750.X
J Kawanishi, J Kato, K Sasaki, S Fujii, N Watanabe, Y Niitsu, Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Molecular and Cellular Biology. ,vol. 15, pp. 1175- 1181 ,(1995) , 10.1128/MCB.15.3.1175
Elizabeth Won, Yelena J. Janjigian, David H. Ilson, HER2 directed therapy for gastric/esophageal cancers. Current Treatment Options in Oncology. ,vol. 15, pp. 395- 404 ,(2014) , 10.1007/S11864-014-0292-6